Multiple studies have reported reduced MFN2 levels in the context of obesity, diabetes, and high-fat diets in the SM, and modulation of its expression can reverse, prevent, or ameliorate SM mitochondrial function [61]. Here, MFN2 is linked to obesity due to melanocortin 4 receptor deficiency.